TrialThe oncologist2019

aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal Cancer.

Yoshihiko Fujita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.